REZUROCK (belumosudil) tablets logo

For US Health Care
Professionals Only


young woman holding a tablet device
young woman holding a tablet device

Complete the form below to get the latest updates about
REZUROCK and/or to connect with a representative

All fields required.

By clicking SUBMIT, you agree to the Sanofi Terms of Use and Privacy Policy and to receive product and educational information from Sanofi, its affiliates and its service providers.

cGVHD, chronic graft-versus-host disease; MOA, mechanism of action.

Usage of cookies

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

More information on cookies

Please verify that you are a US health care professional

This information is intended for US health care professionals.

I am a US health care